Carl Zeiss Meditec (ETR:AFX) has been assigned a €55.00 ($67.90) target price by analysts at Berenberg Bank in a report issued on Monday. The brokerage currently has a “neutral” rating on the stock. Berenberg Bank’s price target would indicate a potential upside of 10.53% from the company’s previous close.
Several other equities research analysts have also commented on the stock. Hauck & Aufhaeuser set a €62.50 ($77.16) price target on shares of Carl Zeiss Meditec and gave the stock a “buy” rating in a research note on Thursday. Deutsche Bank set a €48.00 ($59.26) price target on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Monday, January 22nd. Nord/LB set a €60.00 ($74.07) price target on shares of Carl Zeiss Meditec and gave the stock a “buy” rating in a research note on Tuesday, December 12th. Independent Research set a €54.00 ($66.67) price target on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Friday, December 8th. Finally, Commerzbank set a €42.00 ($51.85) price objective on shares of Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Friday, December 8th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of €52.75 ($65.12).
Shares of Carl Zeiss Meditec (AFX) traded up €0.38 ($0.47) during trading hours on Monday, reaching €49.76 ($61.43). 115,700 shares of the company traded hands, compared to its average volume of 93,147. Carl Zeiss Meditec has a 12-month low of €36.56 ($45.14) and a 12-month high of €55.25 ($68.21). The firm has a market cap of $4,450.00 and a price-to-earnings ratio of 31.69.
TRADEMARK VIOLATION WARNING: This piece was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2018/02/12/carl-zeiss-meditec-afx-given-a-55-00-price-target-at-berenberg-bank.html.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.